|Caerus Investment Partners||Chicago, Illinois, United States|
|CITA Investissement||France, Ile-de-France, Paris|
|Essential Pharma||Japan, Tokyo|
|GB-VI Growth Fund Investment Limited Partnership||-|
|Georgia State University||Atlanta, Georgia, United States|
|Henry Crown and Company||-|
|INTCO Medical||China, Shandong, Zibo|
|Kangmei Pharmaceutical||China, Guangdong Province, Huizhou|
|Macomb Community College||Michigan, United States, Warren|
|MassChallenge Switzerland||Renens, Switzerland, Vaud|
|Mount Sinai Innovation Partners||-|
|National Capital Consortium for Pediatric Device Innovation||-|
|Oracle Investment Management Inc.||Connecticut, Greenwich, United States|
|Pacific Technology Partners||Seattle, United States, Washington|
|SiC Processing||Bavaria, Germany, Hirschau|
|Steel City Capital Funding||-|
|The Hina Group||California, San Francisco, United States|
|$10M||16 Dec 2020||San Francisco, California, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.